CAS 6939-11-3: 5-methoxy-2-thioxo-2,3-dihydropyrimidin-4(1H)-one

5-Methoxy-2-Sulfanyl-4-Pyrimidinol

2-Mercapto-5-methoxy-pyrimidin-4-ol (2MMP) is a vaccine that can be used to prevent tuberculosis. It is an active compound of the drug Rifamycin SV and belongs to the class of rifamycins. 2MMP has been shown to inhibit the growth of Mycobacterium tuberculosis in vitro, which may be due to its ability to bind DNA and prevent transcription. The vaccine has also been shown to increase antibody titres against Mycobacterium avium complex. 2MMP has been analyzed in populations with a high incidence of tuberculosis and prioritized for vaccine development because it is effective in preventing disease and controlling epidemics. The use of this vaccine will have an impact on stakeholders, including pharmaceutical companies, healthcare providers, patients, and governments.